⌘K

Home/Filings/4/0001181431-13-015377

4//SEC Filing

FERRARI LOUIS 4

Accession 0001181431-13-015377

CIK 0000722104other

View on SEC.gov Company Profile

Filed

Mar 6, 7:00 PM ET

Accepted

Mar 7, 4:47 PM ET

Size

10.3 KB

Accession

0001181431-13-015377

Insider Transaction Report

Form 4

Period: 2013-03-05

SAVIENT PHARMACEUTICALS INCSVNT

SVP, North American Commerical

Transactions

Award
Option to Purchase Common Stock
2013-03-05+180,000→ 180,000 total
Exercise: $0.94Exp: 2023-03-05→ Common Stock (180,000 underlying)
Award
Option to Purchase Common Stock
2013-03-05+60,200→ 60,200 total
Exercise: $2.26Exp: 2022-02-01→ Common Stock (60,200 underlying)
Award
Option to Purchase Common Stock
2012-07-09+150,000→ 150,000 total
Exercise: $0.56Exp: 2022-07-09→ Common Stock (150,000 underlying)

Holdings

Common Stock
308,459

Footnotes (3)

[F1]These options will vest in proportional 25% increments on each of the first four anniversaries of the grant date, March 5, 2013.
[F2]These options reflect the vesting of performance options that were granted to the reporting person effective February 1, 2012.
[F3]These performance options were granted effective July 9, 2012 and vest, if at all, in proportional 25% increments if the closing price of Savient's common stock during any period of 30 consecutive calendar days equals or exceeds certain pre-agreed share prices.

Documents

1 file

4
rrd373150.xmlPrimary
FERRARI FORM 4

Issuer

SAVIENT PHARMACEUTICALS INC

CIK 0000722104

Entity typeother

Related Parties

1

filerCIK 0001513697

Filing Metadata

Form type: 4
Filed: Mar 6, 7:00 PM ET
Accepted: Mar 7, 4:47 PM ET
Size: 10.3 KB

View on SEC.gov